Amino acid supplementation differentially modulates STAT1 and STAT3 activation in the myocardium exposed to ischemia/reperfusion injury.

[1]  R. Knight,et al.  The FASEB Journal • FJ Express Full-Length Article Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia/reperfusion injury , 2022 .

[2]  V. Hwa,et al.  Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway. , 2006, Experimental cell research.

[3]  Mohammad Saleem,et al.  Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. , 2006, Cancer research.

[4]  D. Layman,et al.  Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. , 2006, The Journal of nutrition.

[5]  I. Komuro,et al.  G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes , 2005, Nature Medicine.

[6]  A. Stephanou,et al.  Opposing actions of STAT-1 and STAT-3 , 2005, Growth factors.

[7]  R. Knight,et al.  Epigallocatechin‐3‐gallate inhibits STAT‐1 activation and protects cardiac myocytes from ischemia/reperfusion‐ induced apoptosis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  C. Proud.  Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. , 2004, Cardiovascular research.

[9]  Michael D. Schneider,et al.  Signal Transducer and Activator of Transcription 3 Is Required for Myocardial Capillary Growth, Control of Interstitial Matrix Deposition, and Heart Protection From Ischemic Injury , 2004, Circulation research.

[10]  J. Gardin,et al.  Nutritional supplementation with mixed essential amino acids enhances myocyte survival, preserving mitochondrial functional capacity during ischemia-reperfusion injury. , 2004, The American journal of cardiology.

[11]  A. Stephanou.  Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury. , 2003, European cytokine network.

[12]  D. Latchman,et al.  The C‐terminal activation domain of the STAT‐1 transcription enhances ischemia/reperfusion‐induced apoptosis in cardiac myocytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  R. Knight,et al.  Different Signaling Pathways Induce Apoptosis in Endothelial Cells and Cardiac Myocytes During Ischemia/Reperfusion Injury , 2002, Circulation research.

[14]  R. Knight,et al.  Induction of Apoptosis and Fas Receptor/Fas Ligand Expression by Ischemia/Reperfusion in Cardiac Myocytes Requires Serine 727 of the STAT-1 Transcription Factor but Not Tyrosine 701* , 2001, The Journal of Biological Chemistry.

[15]  R. Knight,et al.  Distinct initiator caspases are required for the induction of apoptosis in cardiac myocytes during ischaemia versus reperfusion injury , 2001, Cell Death and Differentiation.

[16]  P. Boekstegers,et al.  Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. , 2000, Circulation.

[17]  R. Knight,et al.  Ischemia-induced STAT-1 Expression and Activation Play a Critical Role in Cardiomyocyte Apoptosis* , 2000, The Journal of Biological Chemistry.

[18]  D. Latchman,et al.  Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters , 2000, Cell Death and Differentiation.

[19]  Aseem Kumar,et al.  Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases , 1997 .

[20]  P. Anversa,et al.  Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. , 1996, Journal of molecular and cellular cardiology.

[21]  S. Mariotto,et al.  Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.